메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색

초록· 키워드

오류제보하기
Atypical antipsychotics (APDs) such as clozapine, but not the typical APD haloperidol, produce greater increases in dopamine and acetylcholine release in rat medial prefrontal cortex (mPFC), compared to the nucleus accumbens (NAC) or striatum (STR), a mechanism postulated to lead to improvements of negative symptoms and neurocognitive deficits in patients with schizophrenia. The present study determined whether typical and atypical APDs modulate dopamine and acetylcholine release in the ventral hippocampus (vHIP) as well as mPFC, both of which are important to neurocognitive functions in schizophrenia. Clozapine (3 and 10 mg/kg) produced comparable increases in dopamine release in the mPFC and vHIP. Clozapine (3 and 10 mg/kg) also increased acetylcholine release in both regions, without significant effect at 3 mg/kg in the mPFC. The perfusion of tetrodotoxin(1 μM) into the vHIP eliminated clozapine-induced dopamine and acetylcholine release in that region. Haloperidol (0.1, but not 1 mg/kg) only increased dopamine release in the mPFC, without an effect of all the doses on either release in either region. These results suggest that clozapine, but not haloperidol, increases dopamine and acetylcholine release in the vHIP as well as in the mPFC. This may further indicate that clozapine and perhaps related atypical APDs may differ from the typical APDs such as haloperidol in enhancing dopamine and acetylcholine transmission in the hippocampal-PFC pathway that may be responsible for neurocognitive deficits in schizophrenia.

목차

등록된 정보가 없습니다.

참고문헌 (0)

참고문헌 신청

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!

이 논문의 저자 정보

최근 본 자료

전체보기

댓글(0)

0